UK Adds MMR Vaccine To Export Ban List
Parallel Traders Say List Is Non-Transparent & Misdirected
There are now 31 medicines on the UK’s list of products that cannot be parallel exported to other European Economic Area countries as part of government efforts to tackle drug shortages. The parallel trade industry has attacked the initiative for lack of transparency.
You may also be interested in...
Parallel traders play a major role in injecting competition into the EU pharmaceutical market place and alleviating drug shortages, says Kohlpharma’s Jörg Geller, who has just taken over at the helm of the parallel distributors’ representative body in Europe.
A ban on the parallel exporting of medicines from Belgium did not achieve the desired objective of preventing drug shortages, and was also against EU rules, the Constitutional Court has ruled.
As companies evaluate scores of products for the possible presence of nitrosamine impurities, the EU regulator has listed potential sources of contamination identified to date to help sponsors develop a risk-based approach for their evaluations.